UK markets closed

Hims & Hers Health, Inc. (HIMS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
21.77-1.48 (-6.37%)
At close: 04:00PM EDT
21.69 -0.08 (-0.37%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.68B
Enterprise value 4.48B
Trailing P/E N/A
Forward P/E 144.93
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.88
Price/book (mrq)13.57
Enterprise value/revenue 4.67
Enterprise value/EBITDA 2.12k

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 3142.70%
S&P500 52-week change 318.96%
52-week high 325.74
52-week low 35.65
50-day moving average 320.68
200-day moving average 312.85

Share statistics

Avg vol (3-month) 311.26M
Avg vol (10-day) 38.75M
Shares outstanding 5206.41M
Implied shares outstanding 6214.79M
Float 8184.8M
% held by insiders 111.97%
% held by institutions 162.51%
Shares short (15 Jul 2024) 419.81M
Short ratio (15 Jul 2024) 41.98
Short % of float (15 Jul 2024) 410.53%
Short % of shares outstanding (15 Jul 2024) 49.22%
Shares short (prior month 14 Jun 2024) 417M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.25%
Operating margin (ttm)3.59%

Management effectiveness

Return on assets (ttm)-0.79%
Return on equity (ttm)-0.71%

Income statement

Revenue (ttm)959.4M
Revenue per share (ttm)4.55
Quarterly revenue growth (yoy)45.80%
Gross profit (ttm)N/A
EBITDA 5.2M
Net income avi to common (ttm)-2.35M
Diluted EPS (ttm)-0.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)203.59M
Total cash per share (mrq)0.95
Total debt (mrq)11.82M
Total debt/equity (mrq)3.43%
Current ratio (mrq)2.81
Book value per share (mrq)1.61

Cash flow statement

Operating cash flow (ttm)89.84M
Levered free cash flow (ttm)60.33M